CRYSTALLINE FORM III OF N0(-(((S)-4-OXO-2-AZETIDINYL)-CARBONYL)-L-HISTIDYL-L-PROLINAMIDE

摘要

The invention provides a crystallization procedure for forming novel crystalline N alpha -[[(S)-4-oxo-2-Azetidinyl]-Carbonyl]-L-Histidyl-L-prolinamide dihydrate which is stable at ambient temperature and humidity and so is advantageous for storage, handling and medicament formulation.